statistiche ricercatore

Continente	#
NA - Nord America	1.722
EU - Europa	1.528
AS - Asia	827
SA - Sud America	115
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	22
OC - Oceania	5
Totale	4.241

Nazione	#
US - Stati Uniti d'America	1.678
DE - Germania	515
FI - Finlandia	279
GB - Regno Unito	270
CN - Cina	218
SG - Singapore	215
SE - Svezia	166
VN - Vietnam	127
IT - Italia	94
HK - Hong Kong	91
BR - Brasile	85
RU - Federazione Russa	63
UA - Ucraina	36
TR - Turchia	31
FR - Francia	28
IN - India	26
KR - Corea	24
CA - Canada	22
BD - Bangladesh	19
BG - Bulgaria	16
IE - Irlanda	15
JP - Giappone	13
MX - Messico	11
ID - Indonesia	8
IQ - Iraq	7
LT - Lituania	7
PK - Pakistan	7
AR - Argentina	6
CL - Cile	6
EC - Ecuador	6
ES - Italia	6
NL - Olanda	6
PL - Polonia	6
PY - Paraguay	6
RO - Romania	6
ZA - Sudafrica	6
AE - Emirati Arabi Uniti	5
BE - Belgio	5
IR - Iran	5
JO - Giordania	5
NZ - Nuova Zelanda	5
PH - Filippine	5
EG - Egitto	3
IL - Israele	3
KE - Kenya	3
TH - Thailandia	3
UZ - Uzbekistan	3
AL - Albania	2
AZ - Azerbaigian	2
CO - Colombia	2
CR - Costa Rica	2
CU - Cuba	2
CW - ???statistics.table.value.countryCode.CW???	2
HU - Ungheria	2
LK - Sri Lanka	2
NO - Norvegia	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
VE - Venezuela	2
AO - Angola	1
AT - Austria	1
CH - Svizzera	1
CI - Costa d'Avorio	1
DM - Dominica	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EU - Europa	1
GT - Guatemala	1
JM - Giamaica	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
MU - Mauritius	1
MY - Malesia	1
NG - Nigeria	1
OM - Oman	1
PE - Perù	1
PS - Palestinian Territory	1
SC - Seychelles	1
SN - Senegal	1
SV - El Salvador	1
TG - Togo	1
TJ - Tagikistan	1
UY - Uruguay	1
Totale	4.222

Nome	#
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors	773
Synthesis and pharmacological evaluation of 1-benzylpiperazine and 4-benzylpiperidine as potent sigma ligands.	461
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study	458
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression	448
Synthesis and biological evaluations of 4-alkyl-1-Arylpiperazine derivatives: SAR at 5-HT1A and 1 –Adrenoreceptor	395
1-(1,4-Dioxa-spiro[4.5]dec-2ylmethyl)-4-(2-methoxy-phenyl)-piperazine: SAR at alpha1 and 5-HT1A Receptors.	357
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors	353
Heteroarylphenoxyethyl amine as selective 5-HT1A receptor ligands: synthesis and structure-activity ralationship studies.	271
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives	264
Investigation within a new series of heterocyclic biaryl piperazines acting at 5-HT1A serotoninergic receptors	251
Structure Activity Relationship at 5-HT1A receptors within a novel series of spiro-1,3-Dioxolane-based ligands	210
Totale	4.241

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	193	0	0	0	6	20	23	6	9	35	25	41	28
2022/2023	292	40	44	18	33	26	40	9	24	36	2	15	5
2023/2024	161	4	8	21	9	43	11	16	23	1	2	17	6
2024/2025	1.271	16	9	21	39	100	198	314	178	200	22	69	105
2025/2026	1.142	88	52	104	168	224	79	131	45	88	92	26	45
2026/2027	226	9	49	101	67	0	0	0	0	0	0	0	0
Totale													4.241